(AVX:Australian Stock Exchange Ltd)
David A. Cooper M.D., DSc, AO
Member of Scientific Advisory Board, Avexa Ltd.
|Age||Total Calculated Compensation||This person is connected to 42 board members in 3 different organizations across 3 different industries.|
See Board Relationships
Dr. David A. Cooper MD, DSc, AO serves as Professor of Medicine of University of New South Wales. Dr. Cooper serves as the Head of the Immunology/HIV/Infectious Diseases Clinical Service Unit of St Vincent's Hospital, Sydney. He serves as Director of the National Centre in HIV Epidemiology and Clinical Research, Sydney, Australia. Dr. Cooper serves as Director of Centre for Applied Medical Research St. Vincent's Hospital Sydney, Australia. Internationally, Dr. Cooper ...
61-63 Camberwell RoadPhone: 61 3 8888 1040
Hawthorn East, Victoria 3123
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Lamberto Andreotti||Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee|
Bristol-Myers Squibb Company
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|Kenneth C. Frazier||Chairman, Chief Executive Officer and President|
Merck & Co. Inc.
|$1.5M||Compensation as of Fiscal Year 2013.|